Cited by 966Bone Metabolism and DiseasesBone health and osteoporosis researchBone and Dental Protein Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Poole, Kenneth E. S., Van Bezooijen, Rutger L., Loveridge, Nigel, Hamersma, Herman, Papapoulos, Socrates E., Löwik, Clemens W., Reeve, Jonathan·2005·The FASEB Journal

DOI 10.1096/fj.05-4221fje

Open this paper in CoChat — free account

Abstract

Osteocytes are the most abundant cells in bone and are ideally located to influence bone turnover through their syncytial relationship with surface bone cells. Osteocyte‐derived signals have remained largely enigmatic, but it was recently reported that human osteocytes secrete sclerostin, an inhibitor of bone formation. Absent sclerostin protein results in the high bone mass clinical disorder sclerosteosis. Here we report that within adult iliac bone, newly embedded osteocytes were negative for sclerostin staining but became positive at or after primary mineralization. The majority of mature osteocytes in mineralized cortical and cancellous bone was positive for sclerostin with diffuse staining along dendrites in the osteocyte canaliculi. These findings provide for the first time in vivo evidence to support the concept that osteocytes secrete sclerostin after they become embedded in a mineralized matrix to limit further bone formation by osteoblasts. Sclerostin did not appear to influence the formation of osteocytes. We propose that sclerostin production by osteocytes may regulate the linear extent of formation and the induction or maintenance of a lining cell phenotype on bone surfaces. In doing so, sclerostin may act as a key inhibitory signal governing skeletal microarchitecture.

Integrity signals

Registry

Crossref · 10.1096/fj.05-4221fje

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
Sclerostin Binds to LRP5/6 and Antagonizes Canonical Wnt Signaling
Li, X., Zhang, Y., Kang, H., Liu, W., Liu, P., Zhang, J., Harris, S. E., & Wu, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413274200 · Cited by 1,366
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
Balemans, W. (2001) · Human Molecular Genetics · doi:10.1093/hmg/10.5.537 · Cited by 1,147
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
Winkler, D. G., Sutherland, M. K., Geoghegan, J. C., Yu, C., Hayes, T., Skonier, J. E., Shpektor, D., Jonas, M., Kovacevich, B. R., Staehling‐Hampton, K., et al. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg599 · Cited by 1,114
Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing Protein
Brunkow, M. E., Gardner, J. C., Van Ness, J., Paeper, B. W., Kovacevich, B. R., Proll, S., Skonier, J. E., Zhao, L., Sabo, P. J., Fu, Y.-H., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/318811 · Cited by 1,011
Self-citation
Sclerostin Is an Osteocyte-expressed Negative Regulator of Bone Formation, But Not a Classical BMP Antagonist
van Bezooijen, R. L., Roelen, B. A. J., Visser, A., van der Wee-Pals, L. J. A., de Wilt, E., Karperien, M., Hamersma, H. A., Papapoulos, S. E., ten Dijke, P., & Löwik, C. W. G. M. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031454 · Cited by 893
Self-citation
Loss of Osteocyte Integrity in Association with Microdamage and Bone Remodeling After Fatigue In Vivo
Verborgt, O., Gibson, G. J., & Schaffler, M. B. (2000) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2000.15.1.60 · Cited by 731
Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells
Dobnig, H., & Turner, R. T. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628403 · Cited by 614
Periosteum: biology, regulation, and response to osteoporosis therapies
Allen, M. R., Hock, J. M., & Burr, D. B. (2004) · Bone · doi:10.1016/j.bone.2004.07.014 · Cited by 449
The Death of Osteocytes via Apoptosis Accompanies Estrogen Withdrawal in Human Bone
Tomkinson, A., REEVE, J., Shaw, R. W., & Noble, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.9.4200 · Cited by 417
Self-citation

Show all 34 references

Research works printed but not linked: 2

Warmington K., 2004, Sclerostin antagonism in adult rodents, via monoclonal antibody mediated blockade, increases bone mineral density and implicates sclerostin as a key regulator of bone mass during adulthood (Abstract), J. Back Musculoskeletal. Rehabil., 19, S56
10.1210/jc.82.9.3128 · DOI

Sorted by citations

Items 801–900 of 966

The Variety of Osteocyte Function
O’Brien, C. A. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-800571-2.00006-2 · Cited by 1
DISORDERS OF CALCIUM METABOLISM AND BONE MINERALIZATION
Clarke, B. L., & Khosla, S. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50043-3 · Cited by 1
[Sclerostin expression in periodontal ligaments during movement of orthodontic teeth in rats].
Yiwen, C., Gao, S., Xu, T., Jiahui, Z., Li, J., Hui-yan, Z., Lu, J., Hu, M., & Liu, Z. (2016) · PubMed Central · doi:10.7518/hxkq.2016.03.005 · Cited by 1
Role of sclerostin in the pathogenesis of chronic kidney disease-mineral bone
Asamiya, Y., Tsuchiya, K., & Nitta, K. (2016) · Cited by 1
Zahneruption und Zahnbewegung bei kongenitaler Retention mit Mutation des PTH1-Rezeptor-Gens
Danz, J. C. (2018) · Informationen aus Orthodontie & Kieferorthopädie · doi:10.1055/a-0648-8013 · Cited by 2
FGF23 and bone disease
Perry, K. W. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818036-5.00013-6 · Cited by 1
Bone Health: Basic and Applied Bone Biology
Miedany, Y. M. E. (2022) · Springer eBooks · doi:10.1007/978-3-030-87950-1_1 · Cited by 1
Biphasic and Dosage-Dependent Regulation of Osteoclastogenesis by β-Catenin
Wan, Y., Wei, W., Zeve, D., Wang, X., Du, Y., Suh, J. M., Zerwekh, J. E., Dechow, P. C., & Graff, J. M. (2011) · The Endocrine Society eBooks · doi:10.1210/endo-meetings.2011.part1.or3.or02-2 · Cited by 1
Exploring the Role of Urocortin in Osteoporosis
Ismail, O. M., El-Omar, O., & Said, U. N. (2023) · Cureus · doi:10.7759/cureus.38978 · Cited by 1
Buds of new bone formation within the Femoral Head of Hip Fracture Patients Coincide with Zones of Low Osteocyte Sclerostin
Sano, H., Whitmarsh, T., Skingle, L., Shimakura, T., Yamamoto, N., Compston, J. E., Takahashi, H. E., & Poole, K. E. S. (2023) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4898 · Cited by 1
Self-citation
Association Between Plasma Sclerostin Levels and Body Mass Index in Women With Polycystic Ovary Syndrome
Bertizlioğlu, M., Kebapçılar, A. G., Kebapçılar, L., Akyürek, F., Sert, Z. S., & Çelık, Ç. (2023) · Cureus · doi:10.7759/cureus.48875 · Cited by 1
Mechanobiology regulation
McEvoy, E., & McNamara, L. M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91821-3.00007-4 · Cited by 1
Emerging roles of osteocytes in the regulation of bone and skeletal muscle mass
Moin, M. R., Das, S., & Sanyal, S. (2024) · Journal of Molecular Endocrinology · doi:10.1530/jme-24-0033 · Cited by 1
Ostéopathies
Spas-Defasque, E., Renaud, A., Cortet, B., Herbinet, P., Boutry, N., & Cotten, A. (2013) · Elsevier eBooks · doi:10.1016/b978-2-294-71924-0.00013-9 · Cited by 1
Bone mineral density and serum sclerostin levels in early ankylosing spondylitis: their possible correlation with a panel of disease activity and structural change parameters
Khalek, M. A. A., Nassar, W. A. M., El-Sherbeny, A. A., & Escandar, R. T. (2013) · Egyptian Rheumatology and Rehabilitation · doi:10.7123/01.err.0000426388.95682.a7 · Cited by 1
Vitamin D Activities in Osteocytes
Anderson, P., Atkins, G. J., Morris, H. A., & Findlay, D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809965-0.00019-7 · Cited by 2
Pathophysiology of Osteoporosis
Ferrari, S. (2018) · Springer eBooks · doi:10.1007/978-3-319-26757-9_1 · Cited by 1
Wnt signaling and bone cell activity
Williams, B. O., & Johnson, M. L. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00008-7 · Cited by 1
Acute Response of Sclerostin to Whole-body Vibration with Blood Flow Restriction
Gapper, K. S., Stevens, S., Antoni, R., Hunt, J. E. A., & Allison, S. J. (2021) · International Journal of Sports Medicine · doi:10.1055/a-1422-3376 · Cited by 1
Evaluation of Serum Level of Sclerostin in Patients with Psoriatic Arthritis
Sorour, N. E., Hafeez, N. A. A., Akl, E. M., Mowafy, M. A., & MOHAMED, A. A. A. (2021) · Benha Journal of Applied Sciences · doi:10.21608/bjas.2021.169470 · Cited by 1
Effect of type 2 diabetes on bone cell behavior
Vaidya, R., Church, A. E., & Karim, L. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821070-3.00001-5 · Cited by 1
Osteocytes and Bone Regeneration
Atkins, G. J., Prideaux, M., & Findlay, D. M. (2014) · Mechanical engineering series · doi:10.1007/978-3-319-13266-2_3 · Cited by 1
脊椎椎体骨折を伴う骨粗鬆症に対するロモソズマブの治療成績
裕, 野., & 茂治, 野. (2021) · Orthopedics & Traumatology · doi:10.5035/nishiseisai.70.323 · Cited by 1
Platelet-Rich Plasma Contains High Concentrations of DKK1, A Potent Inhibitor of Wnt Signaling that Limits Bone Regeneration and Hair Growth
Kostenuik, P. J. (2023) · Journal of Orthopedics & Bone Disorders · doi:10.23880/jobd-16000243 · Cited by 1
Bone Cell Function: A Review
Nguyen, H. N., & Kampa, N. (2013) · The Thai Journal of Veterinary Medicine · doi:10.56808/2985-1130.2488 · Cited by 1
Cell Biology of Craniofacial Bone: Osteocytes
Bonewald, L. F. (2012) · doi:10.1002/9781118704868.ch8 · Cited by 1
MARKERS OF BONE TURNOVER IN PRECLINICAL DEVELOPMENT OF DRUGS FOR SKELETAL DISEASES
Rissanen, J. P. (2013) · UTUPub (University of Turku) · Cited by 1
Inflammation-driven bone formation in ankylosing spondylitis: characterisation of the proteoglycan-induced spondylitis mouse model
Tseng, H. (2015) · The University of Queensland · doi:10.14264/uql.2015.886 · Cited by 1
Modelling Osteocyte Network Formation: Healthy and Cancerous EnvironmentsPreprint
Taylor‐King, J. P., Buenzli, P. R., Chapman, S. J., Lynch, C. C., & Basanta, D. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/729046 · Cited by 1
Time-sequence of biomechanical adaption in trabecular tissue during estrogen deficiency
O’Sullivan, L. (2020) · Arrow@dit (Dublin Institute of Technology) · doi:10.13025/17271 · Cited by 1
Bone and blood: IL-19 to the rescue
Pajevic, P. D. (2021) · Blood · doi:10.1182/blood.2021011367 · Cited by 1
Inflammation and Bone Destruction: Pathogenesis and Therapeutic Intervention
Shehabeldin, M., Intini, G., Sfeir, C. S., & Dyke, T. E. V. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11199-7 · Cited by 1
Culture of Saos-2 cells under hypoxic conditions stimulates rapid differentiation to an osteocyte-like stagePreprint
Zelmer, A. R., Starczak, Y., Solomon, L. B., Richter, K., Yang, D., & Atkins, G. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.23.537998 · Cited by 1
Fisiología del hueso y marcadores bioquímicos del recambio óseo
Canelas, A. C., Cenarruzabeitia, N. V., & Corrales, E. P. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00002-2 · Cited by 1
Osteoporose - Das Metabolische Syndrom des Knochens - Wirkungen von Ecdyson und Vitamin D auf den postmenopausalen, osteoporotischen Knochen im Zusammenhang mit dem Metabolischen Syndrom
Dannenberg, L. (2014) · doi:10.53846/goediss-4542
Desarrollo normal del esqueleto y regulación de la formación y reabsorción óseas
Moreno, P. R., Reyes‐García, R., & Martín, A. G. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00001-0 · Cited by 1
The regulatory role of osteoblasts in castration-resistant growth of prostate cancer
Thulin, M. H. (2015)
Pharmacological Treatment of Osteoporosis
Malouf, J., & Güerri‐Fernández, R. (2012) · InTech eBooks · doi:10.5772/30552
Specific Proteases for Osteoarthritis Diagnosis and Therapy
Yuan, X., Zhang, L., & Wu, Y. (2015) · InTech eBooks · doi:10.5772/60570
Exploiting knowledge of mesenchymal stromal cells in vivo for bone disease therapy development
Cuthbert, R. (2014) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Clinical Correlate: Van Buchem Disease
Prins, H., Bronckers, A. L. J. J., & Klein‐Nulend, J. (2012) · doi:10.1002/9781118704868.ch9
Overvloed en onbehagen. Uitdagingen voor de moderne endocrinologie.
Smit, J. W. A. (2008) · Leiden Repository (Leiden University)
Characterization of the osteopetrotic Clcn7-/- mouse mutant rescued by osteoclast-specific expression of ClC-7
Supanchart, C. (2009) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-7105
Ciblage thérapeutique des tumeurs osseuses primitives par transfert de gène
Lamoureux, F. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Differentiation of osteoblasts to osteocytes in 3D type I collagen gels - a novel tool to study osteocyte responses to mechanical loading
Scully, N. E. E. (2015) · ORCA Online Research @Cardiff (Cardiff University)
Evaluation of the impact of mechanical vibration on the adult skeleton
Harris, L. (2015) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
Caracterização morfométrica e molecular do papel de citocinas pró e anti-inflamatórias no processo de reparo ósseo alveolar em condições homeostáticas e infecciosas
Vieira, A. E. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2013.tde-22112013-113101
Integrity of the osteocyte bone cell network in osteoporotic fracture: Implications for mechanical load adaptation
Kuliwaba, J. S., Truong, L.-H., Codrington, J. D., & Fazzalari, N. L. (2010) · IOP Conference Series Materials Science and Engineering · doi:10.1088/1757-899x/10/1/012128
Sclerostin: A Novel Key to Bone and Dental Treatment
Carlo (2012) · Current Research in Dentistry · doi:10.3844/crdsp.2012.18.26
Molecular signaling in bone remodeling: Asia pacific conference 2007
Martin, T. J., & Seeman, E. (2008) · IBMS BoneKEy · doi:10.1138/20080321
Advances in knowledge about induced tooth movement Part 1: the osteocytes
Consolaro, A. G. (2012) · Dental Press Journal of Orthodontics · doi:10.1590/s2176-94512012000300004
Osteocytes, bone remodeling and parathyroid hormone
Datta, N. S. (2012) · Endocrinology Studies · doi:10.4081/es.2012.e8
Experimental and computational investigation into mechanobiology of osteocytes
Mullen, C. A. (2014) · ARAN (University of Galway Research Repository) (Ollscoil na Gaillimhe – University of Galway) · doi:10.13025/15885
Increased Urinary Phosphate Excretion Induced by Fibroblast Growth Factor 23 in Zinc-deficient Rats
Mochizuki, T., Miyazaki, T., & Takenaka, T. (2014) · 微量栄養素研究
The Comparison between Single vs Repeated Administration of Wnt3A of HPDL Cells
Yoshizawa, Y., Ochiai-Shino, H., Tsukinowa, T., Onodera, S., Muramatsu, T., Furusawa, M., & Azuma, T. (2015) · Journal of Hard Tissue Biology · doi:10.2485/jhtb.24.331
O osso como órgão endócrino.
Barros, J. M. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/9s0z-mc96
Osteocytes emerging from obscurity. Meeting report from the 29th Annual Meeting of the American Society for Bone and Mineral Research
Dallas, S. L., & Bonewald, L. F. (2007) · BoneKEy-Osteovision · doi:10.1138/20070286
UPDATE Update in Osteoporosis and Metabolic Bone Disorders
Shoback, D. (2007)
Growth Hormone - Insulin-Like Growth Factor-I (GH-IGF-I) and Mechanical Loading
Callewaert, F., Sinnesael, M., Gielen, E., & Boonen, S. (2010)
The synovio-entheseal complex in enthesoarthritis
Italia, S.-V. (2015)
Immunology of Osteoporosis: A Short-Review
Subaşı, V. (2016) · Journal of Immunology and Clinical Microbiology · doi:10.5455/jicm.6.20160514
Wnt Signaling in Bone
Johnson, M. L., & Recker, R. R. (2008) · Elsevier eBooks · doi:10.1016/b978-012370544-0.50019-7
Regulation of Bone Resorption by PPARγ
Wei, W., & Wan, Y. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-415784-2.00010-5
Pharmacologic Treatment of Osteogenesis Imperfecta
ORWOLL, E. S., & Martin, E. N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-397165-4.00056-3
Shedding quantitative fluorescence light on novel regulatory mechanisms in skeletal biomedicine and biodentistry
Lee, J., & Iimura, T. (2016) · Japanese Dental Science Review · doi:10.1016/j.jdsr.2016.04.005
Circulating Sclerostin in Bone Sclerosing Disorders
van Lierop, A. H., & Papapoulos, S. E. (2016) · Exposure and Health · doi:10.1007/978-94-007-7745-3_39-1
Self-citation
Wnt/Sclerostin and the Relation with Vitamin D in Chronic Kidney Disease
Apetrii, M., & Covic, A. C. (2016) · Springer eBooks · doi:10.1007/978-3-319-32507-1_11
Modulation of osteogenic differentiation in mesenchymal stromal cells
Gaynard, S., Hayes, J. S., & Murphy, M. J. (2016) · Wiley eBooks · doi:10.1002/9781118907474.ch12
The Effects of a Single Bout of Plyometric Exercise on Anabolic and Catabolic Osteokines in Girls and Adolescents
Dekker, J. (2016) · Brock University Digital Repository (Brock University)
An investigation into the role of RANKL and sclerostin in dentoalveolar ankylosis
Coburn, S. J. (2015) · Adelaide Research & Scholarship (AR&S) (University of Adelaide)
Estudio funcional de los polimorfismos del promotor del gen de la esclerostina
Pérez-Campo, F. M., Krebesova, R., Riancho, J., Sañudo, C., & Delgado‐Calle, J. (2016) · Revista de Osteoporosis y Metabolismo Mineral · doi:10.4321/s1889-836x2016000400004
Fibroblastäre Modulatoren der Knochendestruktion
Dankbar, B., & Pap, T. (2016) · Zeitschrift für Rheumatologie · doi:10.1007/s00393-016-0160-9
Effects of the Lyme disease pathogen Borrelia burgdorferi on murine bone biology
Tang, T. (2016) · TSpace (University of Toronto)
Osteoimmunology: An Evolving Discipline
(2013) · Journal of Arthritis · doi:10.4172/2167-7921.1000e108
The microstructure of osteocytic lacunar-canalicular system varies with age and bone mineral density in osteoporotic and osteoarthritic patients
Gao, V. Y. (2025) · Library, Museums and Press - UDSpace (University of Delaware) · doi:10.58088/1d5n-1v53
Osteoporosis Treatment: Bone-Forming Agents
Langdahl, B. L. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.65349-7
Gewinnung und Charakterisierung von osteoblastären Zellen aus dem humanen Alveolarknochen
Dillschneider, D. (2018) · doi:10.53846/goediss-6868
Administração sistêmica de rosiglitazona estimula a apoptose de osteócitos e cementócitos, interferindo no desenvolvimento de lesões periapicais induzidas em camundongos
de Oliveira, K. M. H. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.58.2018.tde-27022018-152210
Transition of Osteoblasts to Osteocytes
Lin, S., Methani, M. M., & Feng, J. Q. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11183-3
Paracrine Modulation of Mechanotransduction
Huang, J., Wang, Z., Brotto, L. S., Varanasi, V. G., Mo, C., & Brotto, M. A. P. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11214-0
Basic Aspects of Osteocyte Function
Delgado‐Calle, J., & Bellido, T. (2020) · Contemporary Endocrinology · doi:10.1007/978-3-319-69287-6_3
The Role of Wnt Signaling in Bone Mechanotransduction
Bullock, W. A. (2019) · IUScholarWorks (Indiana University) · doi:10.7912/c2/2122
Menopause and Bone Metabolism
Brandi, M., & Medio, L. D. (2020) · Endocrinology · doi:10.1007/978-3-030-03594-5_19-1
Assessment of Bone Quality in Pediatric and Adult Patients with Osteoporosis
Tamminen, I. S. (2013) · UEF eRepo (University of Eastern Finland)
Retraction Note: Titanium particles damage osteocytes and inhibit osteoblast differentiation
Chen, L., Wang, Z., Xu, W., & Dong, Q. (2020) · Journal of Experimental Orthopaedics · doi:10.1186/s40634-020-00304-z
Retracted
Peer Review #3 of "Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes (v0.1)"
(2020) · PeerJ · doi:10.7287/peerj.10244v0.1/reviews/3
Therapy of Myeloma Bone Disease
Ntanasis‐Stathopoulos, I., & Terpos, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-63662-3_7
Novel Models to Image and Quantify Bone Drug Efficacy and Disease Progression In Vivo: Addressing the Fragility Phenotype
Surowiec, R. K. (2019) · Deep Blue (University of Michigan)
Systematic Optimization of Bone Pharmaceuticals to Maximize Therapeutic Response in Conditions of Low Bone Mass
Dillstrom, D. (2018) · Deep Blue (University of Michigan)
Supplemental and dietary calcium intakes in postmenopausal women: a series of studies on vascular and bone health
Ong, A. M. (2020) · eScholarship@McGill (McGill) · doi:10.82308/54884
Anabolic and Emerging Therapies
Zhang, J., & Dennison, E. M. (2021) · Springer eBooks · doi:10.1007/978-3-030-78128-6_6
Recent therapeutic approaches in myeloma
Ntanasis‐Stathopoulos, I., & Terpos, E. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00060-8
Osteocytes and bone tumor niche
Terpos, E., & Christoulas, D. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-821666-8.00057-8
Romosozumab Treatment for Osteoporosis: Pharmacological Stimulation of Mechanical Strain-Related Bone Modeling
Sugiyama, T. (2021) · Springer eBooks · doi:10.1007/978-981-16-5613-2_25
Bone Remodeling and Modeling: Therapeutic Targets for the Treatment of Osteoporosis
Langdahl, B. L. (2021) · Springer eBooks · doi:10.1007/978-981-16-5613-2_8
Involvement of osteocytes in cancer bone niche
Terpos, E., & Christoulas, D. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-416721-6.00006-6
Clinical Application of Monoclonal Antibodies: Key Technological Advances and Treatment of Osteoporosis
Lim, S. Y. (2022) · Springer series in biomaterials science and engineering · doi:10.1007/978-981-16-7439-6_5
Antibody Treatment and Osteoporosis: Clinical Perspective
Brunetti, G., Todisco, S., & Grano, M. (2022) · Springer series in biomaterials science and engineering · doi:10.1007/978-981-16-7439-6_6
Parathyroid Hormones
Hénaff, C. L., & Partridge, N. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-813814-4.00022-5 · Cited by 1
Bone Development and Remodeling
Maes, C., & Kronenberg, H. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00059-9

Authors: Poole, K. E. S., Van Bezooijen, R. L., Loveridge, N., Hamersma, H., Papapoulos, S. E., Löwik, C. W., & Reeve, J.
Affiliations: University of Cambridge (GB)
Department of Endocrinology and Metabolic Diseases Leiden University Medical Centre Leiden Netherlands
South Africa
Leiden University (NL)
ORCID: Poole, Kenneth E. S.
Loveridge, Nigel
Hamersma, Herman
Papapoulos, Socrates E.
Löwik, Clemens W.
Reeve, Jonathan
Venue: The FASEB Journal
Publisher: Wiley
Published: 2005-08-25
Volume: 19
Issue: 13
Pages: 1842-1844
ISSN: 0892-6638 (ISSN-L)
1530-6860
DOI: 10.1096/fj.05-4221fje
OpenAlex: W1970864109
Cited by: 965
References: 34
Citations by year: 2026: 21 · 2025: 28 · 2024: 32 · 2023: 39 · 2022: 38 · 2021: 45 · 2020: 74 · 2019: 63 · 2018: 55 · 2017: 53 · 2016: 66 · 2015: 67 · 2014: 55 · 2013: 62 · 2012: 63
FWCI: 10.29
Type: journal article
Language: en
Open access: closed
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: The FASEB Journal (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
National Osteoporosis Society
European Commission (LSHM‐CT‐2003‐503020)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords: sclerostin, osteocytes, bone formation inhibition, sclerosteosis, osteoblasts, bone mineralization, bone lining cells, bone turnover
MeSH terms: Aged, Alkaline Phosphatase, Antibodies, Monoclonal, Biopsy, Bone and Bones, Bone Development, Bone Diseases, Developmental, Bone Resorption, Cell Differentiation, Coloring Agents, Female, Genetic Markers, Humans, Image Processing, Computer-Assisted, Immunohistochemistry, Male, Microscopy, Fluorescence, Middle Aged, Models, Biological, Osteoblasts, Osteocytes, Osteogenesis, RNA, Messenger, Time Factors, Tolonium Chloride, Signal Transduction, Bone Remodeling, Bone Morphogenetic Proteins, Adaptor Proteins, Signal Transducing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks